New Marketing Plan For Maple Pharma Essay

“To improve the health of our community and to deliver effective and efficient healthcare in which our patients and users feel cared for, safe and confident.” Annual Plan 2013/14

As the new vice President of Mayo Clinic, conducting a marketing plan is a must in order to make a better tomorrow for this clinic. Before targeting any specific country, Mayo Clinic needs to increase its brand awareness. If people overseas do not know about them, they will not trust them. Therefore, they will be unwilling to leave their current healthcare and physician. The countries that need to be targeted are countries with poor to no healthcare system. As the case stated, people simply are unwilling to leave their home country to obtain medical care elsewhere. They would much rather stay with their private healthcare and physician that they already feel comfortable with. Unless it is for a big operation or something that is extremely costly, international patients will just not consider coming to the U.S. Yes, word of mouth is the most powerful marketing tool, but when dealing globally, it just doesn’t help as much.

Initially Sun Pharma started its operations with two eastern states i.e. West Bengal and Bihar with only 5 products which were used to treat psychiatric ailments. Sun Pharma’s business is split into US Generics, Indian Branded Generics and Active Pharmaceutical Ingredients. The brands are specifically targeted towards therapy areas which include cardiology, respiratory, gastroenterology, psychiatry, diabetology and neurology. They are involved in making speciality APIs which includes steroids, anti cancers, peptides and hormones. Dosage forms and API’s are manufactured at around 20 plants

Those target markets who rely on Johnson & Johnson health and medical needs are mostly patients, doctors, nurses and civilians. Therefore, the company need to sustain their products and services over all these years to ensure that lower income people and underprivileged patients are able to access on their medicines. This however requires the company to balance patient’s access and competitive dynamics in line with their need as the company need to have enough resources to keep on being innovating, creating new and better medicines and at the same time making sure there will be a fair return to the shareholder as well. Johnson & Johnson also work closely with the governments, physicians, non-government organizations and the international donors all around the world to provide its products within an affordable prices to its

Providing Over-The-Counter medicine Allstar targets people who have common health problems. The best way to segment Allstar’s customers would be by the following two major categories: illness (cold, cough, allergy) and demographics (young singles, young families, mature families, empty nesters, retired). Allstar Brands invests in marketing research to learn about the ever changing preferences and trends of the market. The information the Company gathers from this research is then used to make according decisions to satisfy each particular category of customer.

The management team at the over-the-counter cold medicine (OCM) group of Allstar Brands is looking to utilize revenue generated by Allround to help fund new opportunities in emerging markets. Therefore, it is critical that Allround maintain its market-leading position in terms of market share, profitability, and sales in order to fund these new initiatives.

Wyeth Pharmaceuticals leadership is very committed to quality. Wyeth is a global leader in prescription medications. They are committed to growth and developing new medicinal products in their research and development divisions. The mission and vision statements of Wyeth Pharmaceuticals demonstrate the alignment of quality to the organization’s strategic goals and objectives. .” The vision statement is “Our vision is to lead the way to a healthier world. By carrying out this vision at every level of our organization, we will be recognized by our employees, customers and shareholders as the best pharmaceutical company in the world, resulting in value for all.”(Wyeth.com, 2008)

In 1967, there were twenty-six companies that manufactured vaccines; by 1980 that number dropped to seventeen1. In the past many companies were financially unable to continue to produce vaccines because the profit margins were so low. It is estimated that vaccines represent a mere 2-3% of the worldwide pharmaceutical industry. When looked at from a business vantage it is understandable that few companies would want or be able to enter into such a small portion of the market. By 2003 so many companies had abandoned vaccine

Allergan Brand’s portfolio conveys medicines that address noteworthy expected medical needs in key remedial classifications including: Dermatology and Esthetics; Central Nervous System; Eye Care; Women 's Health and Urology; Gastroenterology; and Cardiovascular ailment and Infectious illness.

One of Sanofi Pasteur’s strengths is their exceptional leadership. In the U.S. division of Sanofi Pasteur, Damian A. Braga serves as the president and the Vice President of Sanofi Pasteur Americas (Our Company-Damian Braga, 2014). He combines a strong impression of civic responsibility and dedication to organizational growth to bring out his unique management style for one of the world’s top vaccine manufacturers. He has had various key positions over the past 22 years with the company, which contributes extensively to his accomplishments. In the United States, Latin America, and Canada business units, Braga is responsible for operations, oversees the annual revenue of over $3.5 billion, and serves as fundamental role in growth and global strategic management in the organization. Each year revenues in the company increased by an average of 18 percent since Braga took office as President in January 2002. Around the same period, the organization 's U.S. workforce increased three times as much and the Swiftwater, PA site multiplied in acreage. Moreover, the organization effectively dispatched a new adult and adolescent booster vaccine to defend against diphtheria, pertussis, and tetanus; a new meningococcal vaccine; and flu vaccine details intended particularly for pediatric and elderly individuals. Under his leadership, these products and new products resulted in additional sales of 5 billion dollars within the Americas

This company profile provides a preliminary investigation and analysis of Novartis International AG, a multinational pharmaceutical company based in Basel, Switzerland. Novartis is one of ten companies the Investment Board will consider for further in-depth research for a multimillion-dollar investment.

Did you know?  Some people feel more pain than others. The reason is probably perception. The brain works by association.  Ibuprofen is analgesic and anti-inflammatory but

This report provides an analytical strategic review of the global pharmaceutical industry; its origin, evolution,

Pharmaceutical quality affects every human being. FDA regulates the quality of pharmaceuticals very carefully. The main regulatory standard for ensuring pharmaceutical quality is the Current Good Manufacturing Practice (CGMPs) regulation for human pharmaceuticals. Consumers expect that each batch of medicines they take will meet quality standards so that they will be safe and effective. Most people, however, are not aware of CGMPs, or how FDA assures that drug manufacturing processes meet these basic objectives. Recently, FDA has announced a number of regulatory actions taken against drug manufacturers based on the lack of CGMPs. This paper discusses some facts that may be helpful in understanding how CGMPs establish the foundation for drug product quality.

This is a strategic analysis of GlaxoSmithKline that examines the key factors that influence the company and its activities. The strategic analysis will examine key factors in the company’s internal and external environment and their influence on the company’s strategies. GlaxoSmithKline is a global healthcare company that offers pharmaceutical, vaccines and consumer products. The company is a product of various mergers, the latest occurring in 2001 between GlaxoWellcome and SmithKline Beecham. The company started in London United Kingdom in 1715 as Plough Court pharmacy and has evolved to become one of the leading global healthcare companies. The healthcare company operates in more than 150 countries with 89 manufacturing locations and research centers in the USA, China, UK and Belgium. In 2015, the company’s sales grew to £23.9 billion from £23.0 billion in 2014 (GlaxoSmithKline plc. 2015).